New molecular assays for cancer diagnosis and targeted therapy.
Why is this work in the frame?
A frame that forgets how it found something cannot be audited. These are the routes that admitted this work.
The three-model screen
all 1,000 screened works →All three models called this out of scope.
Review of molecular assays for cancer diagnosis and targeted therapy; the object is diagnostic technology and its clinical regulation.
The review concerns cancer diagnostic assays and treatments, not research methodology.
Industry-oriented review of molecular diagnostic cancer assays and personalized medicine testing.
Abstract
Microarray multiplex protein measurement of biomarker-based molecular diagnostic and prognostic cancer testing assays is destined to become a large growth segment of the immunodiagnostic industry. Assays encompass immunohistochemistry, fluorescence in situ hybridization, ELISA and sequencing methods that must comply with stringent regulatory specifications. Current test services available range from single-site service-based assays to multi-laboratory testing. Some tests have regulatory approval, whereas others are regulated by the Clinical Laboratory Improvement Act or the College of American Pathologists, or both. Expectations of personalized medicine are building, and the future is expected to bring truly targeted treatments based on test results. In this review, biomarkers, screening, diagnosis, potential prognosis and treatment pertaining to colorectal, breast, and lung cancers are discussed and evaluated. Assay data are expected to improve clinical indices and treatment algorithms, leading to dynamic disease models for real-time, data-modulated patient management.
Stored with the screening record, where it is evidence for the labels above.
The record
- Venue
- PubMed
- Topic
- Advanced Biosensing Techniques and Applications
- Field
- Biochemistry, Genetics and Molecular Biology
- Canadian institutions
- Cytodiagnostics (Canada)
- Funders
- —
- Keywords
- Companion diagnosticMultiplexMedicineBiomarkerTargeted therapyColorectal cancerOncologyCancerBiomarker discoveryPrecision medicinePersonalized medicineLung cancerDiseaseDiagnostic testBreast cancerInternal medicineBioinformaticsPathologyProteomicsBiologyGene
- Has abstract in OpenAlex
- yes